Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
Development services
Early stage drug development company acquisition
Development services : 11 December, 2013
Bridgepoint Development Capital is to acquire Quotient Clinical to increase market penetration for its early stage drug development work
 
Howard Hughes Medical Institute, Lexicon Pharmaceuticals, Nuevolution to collaborate with Duke University
Development services : 13 August, 2013
Nuevolution enters into a scientific collaboration with Duke University, the Howard Hughes Medical Institute, and Lexicon Pharmaceuticals, for the investigation of the biological mechanism of action of a specified GPCR drug target.
 
Blaze Bioscience collaborates with Fred Hutchinson Cancer Research Center to support of optides discovery
Development services : 05 July, 2013
Blaze Bioscience, a privately held biotechnology company developing Tumor Paint technology, is collaborating with Fred Hutchinson Cancer Research Center, one of the USA's top cancer research and prevention centres and pioneer of bone marrow and stem cell transplantation, to support the Hutchinson Center's Optides Discovery Program and advance drug candidates identified using the platform.
 
EPSRC invests into research projects set to make phones, probes and sensors transform healthcare
Development services : 09 May, 2013
A £32 million investment from the Engineering and Physical Sciences Research Council is going to establish three new Healthcare Interdisciplinary Research Collaborations (IRCs) which will fund several innovative projects including: smart-phone test and tracking systems for infectious diseases; fibre optic probes that can monitor people's condition in intensive care; and in-home sensors that can relay patient information to doctors immediately.
 
NAMSA expands microbiology and sterility assurance testing laboratory in Irvine, California
Development services : 28 March, 2013
NAMSA is continuing the organization's steady growth with the expansion of its microbiology laboratory in Irvine, California, USA.
 
Life Technologies sets up international influenza network to monitor vaccine development
Development services : 31 January, 2013
Life Technologies is establshing the Global Influenza Network, a partnership including scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes in a collaborative effort to increase the speed and efficiency of influenza monitoring and vaccine development.
 
Cytel opens Geneva office to extend global clinical development capabilities
Development services : 04 December, 2012
Cytel is opening a new office in Geneva, Switzerland to support the growing demand for clinical research and biostatistical consulting capabilities throughout Europe.
 
Algometron seeks partners to develop pain test that stratifies patients for optimal therapy
Development services : 23 October, 2012
A novel patented technology (Algotect) has been developed by Algometron to accurately identify patients who are cold hyperalgesic and require specific pain management and Algometron is seeking partners interested in commercially developing (RUO, IVD, LDT, CDx) the innovative and proven device which provides real time, cost effective information to support clinicians, research, drug development and clinical trials.
 
Diamyd Medical divests US gene therapy company
Development services : 10 October, 2012
Diamyd Medical enters into an agreement for the sale of the US subsidiary, Diamyd, involved in drug development primarily relating to the NTDDS platform with applications in pain and neuropathy among others.
 
AB SCIEX partners University of Wollongong to advance lipid analysis
Development services : 19 September, 2012
AB SCIEX and the University of Wollongong (UOW) are forming a research partnership to develop lipid analysis capabilities, including the most definitive and comprehensive identification of double bond position in lipids.
 
PerkinElmer creates new personalized Health Innovation Center of Excellence
Development services : 08 June, 2012
PerkinElmer plans to establish a new Personalized Health Innovation Center of Excellence which will focus on accelerating scientific innovation to help researchers who are working to eradicate disease and extend the quality and longevity of life.
 
Nordion opens the Gamma Centre of Excellence in Canada
Development services : 11 May, 2012
Nordion is launching the Gamma Centre of Excellence (GCE), a world-class facility for the advancement of gamma sterilization science.
 
Covidien boosts global research and development presence
Development services : 12 March, 2012
Covidien is opening of four research and development centres in Boulder, Colorado; Hyderabad, India; Irvine, California; and Trevoux, France.
 
Illumina introduces new cancer analysis service
Development services : 20 February, 2012
Illumina launches a Cancer Analysis Service from the Illumina Genome Network (IGN) that applies the high accuracy of Illumina technologies to provide cancer researchers with easily interpretable tumour/normal sequencing data to quickly move their research forward.
 
Scottish Government forges research strategic alliance with PPD
Development services : 13 February, 2012
The Scottish government and Pharmaceutical Product Development (PPD) is forming an alliance designed to increase the amount of clinical research conducted in Scotland, accelerate the development of new medical therapies and enhance health care treatment options for the people of Scotland.
 
British Columbia Cancer Agency joins the Illumina Genome Network
Development services : 20 December, 2011
The British Columbia Cancer Agency's (BCCA) Genome Science Center is joining the Illumina Genome Network (IGN) which is designed to link researchers needing large-scale whole human genome sequencing with leading institutions that provide this application as a service using industry-leading Illumina sequencing platforms.
 
Zimmer to open research and development centre in Beijing
Development services : 05 December, 2011
Zimmer plans to establish a new research and development centre in Beijing, China with the centre becoming the foundation for a network of research and development programs across the region.
 
Quintiles acquires Outcome Sciences to boost late phase research
Development services : 21 October, 2011
Quintiles acquires Outcome Sciences, a privately held outcomes research firm headquartered in Cambridge, Massachisetts, USA.
 
Covidien to open flagship research and development centre in China
Development services : 19 September, 2011
Covidien says Shanghai is to become the site of the company's flagship research and development centre for China.
 
Synergy opens registry to advance neurodegenerative disease research
Development services : 26 August, 2011
Synergy Health Concepts is developing a registry to advance research regarding venous vascular obstructions in neurodegenerative diseases.
 
Caliper partners Catholic Health Initiatives to evaluate new cancer drugs
Development services : 07 April, 2011
Caliper Life Sciences’ Caliper Discovery Alliances and Services (CDAS) unit is forming a research collaboration with Denver-based Catholic Health Initiatives (CHI), one of the USA's largest health systems.
 
PRECOS extends alliance with Argenta to offer drug discovery services
Development services : 23 March, 2011
Preclinical Oncology Services (PRECOS) is extending its alliance with Argenta to continue providing comprehensive oncology-focused drug discovery services.
 
PRECOS webinar focuses on in-vitro and in-vivo modelling of human TME
Development services : 04 March, 2011
Preclinical Oncology Services is to host a new webinar that focuses on the company's cutting-edge technology and innovative ideas on in-vitro and in-vivo modelling of the human tumour micro-environment (TME).
 
PRECOS doubles capacity to support oncology drug discovery expansion
Development services : 15 February, 2011
Preclinical Oncology Services is doubling its capacity to support the strategic growth of the company following the first six months since its spin-out from the University of Nottingham in September 2010.
 
Diamyd begins Phase II clinical trial in USA for evaluating NP2 Enkephalin
Development services : 19 January, 2011
Diamyd doses the first subject in a Phase II clinical trial in the USA evaluating the ability of the candidate drug NP2 Enkephalin to reduce cancer pain.
 
PRECOS signs a global oncology service deal with Janssen Pharmaceutical
Development services : 23 November, 2010
Preclinical Oncology Services (PRECOS) signs a global service agreement with a leading global pharmaceutical company Janssen Pharmaceutical which will see PRECOS provide clinical tumour material, tumour model development, target validation and drug efficacy work to support Janssen's oncology drug discovery, development and biomarker programmes.
 
Quotient Bioresearch opens new radiochemistry facility in Cardiff, UK
Development services : 14 September, 2010
Quotient Bioresearch opens the company’s new, state-of-the-art radiochemistry facility in Cardiff, UK, with a ceremony including a VIP opening by the First Minister of Wales, Carwyn Jones.
 
University spin-out offers new pre-clinical research and development service
Development services : 10 September, 2010
Preclinical Oncology Services (PRECOS), a leading pre-clinical research and development service with a specific focus on oncology, is launched following its spin-out from the University of Nottingham.
 
Vaccines reduces bacterial pneumonia cases in children
Development services : 31 August, 2010
The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, reports a new study which was led by Dr Sonia Saxena of the School of Public Health at Imperial College London.
 
Philips joins Gilde Healthcare III fund for patient-centric healthcare solutions
Development services : 23 August, 2010
Philips joins Gilde Healthcare III - a new venture capital fund focusing on innovative early and growth stage healthcare technology companies in Europe and the USA that are active in developing and commercialising new patient-centric healthcare solutions, medical technologies and therapeutics.
 
Agendia unveils new state-of-the-art genomics laboratory in California
Development services : 09 August, 2010
Agendia inaugurates a new state-of-the-art clinical genomics laboratory in Irvine, California, USA.
 
BioHub launches online global networking platform for biomedical research
Development services : 08 July, 2010
BioHub is launching BioHub-Online.org, a first-of- its-kind online platform to facilitate global networking and collaboration among research scientists.
 
Mayo Clinic partners with University of Illinois to develop new technologies
Development services : 28 June, 2010
Mayo Clinic and the University of Illinois at Urbana-Champaign agree a strategic alliance designed to promote a broad spectrum of collaborative research, development of new technologies and clinical tools, and design and implementation of novel education programmes.
 
First SynCardia Total Artificial Heart Patient is discharged in the USA
Development services : 01 June, 2010
Mayo Clinic Arizona becomes the first hospital in US history to discharge a patient implanted with the SynCardia temporary Total Artificial Heart to wait at home for a matching donor heart.
 
PA Consulting collaborates with 4D Biomedical to develop experimental medicine
Development services : 16 February, 2010
Leading international technology, management and systems consultancy, PA Consulting Group, enters into a strategic agreement with 4D Biomedical, the Cambridge-based specialist Experimental Medicine consultancy, to support the establishment of new collaborations between NHS Trusts, leading biomedical research universities and industry partners to accelerate medical advances, both clinical and value-based.
 
Centre for Therapeutics Discovery makes first call for drug targets
Development services : 05 February, 2010
A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) to fast-track the discovery and development of novel drugs is making its first call for targets.
 
Eppendorf Award for Young European Investigators declares new deadline
Development services : 04 February, 2010
The Eppendorf Award for Young European Investigators acknowledges outstanding contributions to biomedical research in Europe based on methods of molecular biology, including novel analytical concepts.
 
deCODE discovers genetic factors for key clinical measurements of heart activity
Development services : 12 January, 2010
Scientists at deCODE genetics report the discovery of seven novel and common single-letter variations in the sequence of the human genome (SNPs) that are involved in modulating the electrical impulses that govern the working of the heart.
 
MEDICAL INNOVATION – DELIVERING THE FUTURE
Development services : 30 June, 2009
FOCUS ZONE REPORT – Imagine a hospital with an inflatable operating theatre, a robot that helps doctors perform complex surgery and a device that can be used to take out your gallbladder through your belly button.
 
Cytel signs research agreement deal with CDRH
Development services : 23 June, 2009
Cytel, a leading provider of biostatistical software and clinical trial design services, signs a Cooperative Research And Development Agreement (CRADA) with the Center for Devices and Radiological Health (CDRH), a division of the United States Food and Drug Administration (FDA).
 
Medtronic to open new diabetes therapy management centre in San Antonio, Texas
Development services : 13 May, 2009
Medtronic selects San Antonio, Texas, USA as the home of the company’s new Diabetes Therapy Management and Education Center.
 
Tufts Medical Center creates formula for predicting AMD eye disease
Development services : 27 April, 2009
Researchers at Tufts Medical Center create a formula for predicting how likely it is that individuals with certain genetic profiles and lifestyle behaviours will develop advanced Age-related Macular Degeneration (AMD), a potentially blinding condition.
 
InteRNA and Radboud University to develop miRNA-based therapeutics
Development services : 24 April, 2009
InteRNA Technologies and Radboud University Nijmegen Medical Centre confirm a research agreement to develop microRNA (miRNA)-based therapeutics for prostate cancer.
 
London Centre for Nanotechnology win grant to develop HIV monitor
Development services : 08 April, 2009
A new device that enables people living with HIV to monitor their own health and the effectiveness of their treatments will be developed by researchers from the London Centre for Nanotechnology thanks to a £2 million grant.
 
DIAGNOSTICS – INNOVATION FOCUS
Development services : 27 February, 2009
FOCUS ZONE REPORT – This week Philips has announced the first 3D imaging results obtained using a new imaging technology called Magnetic Particle Imaging (MPI), which uses the magnetic properties of iron-oxide nanoparticles injected into the bloodstream, has been used in a pre-clinical study to generate unprecedented real-time images of arterial blood flow and volumetric heart motion.
 
DIAGNOSTICS – RESEARCH FOCUS
Development services : 27 February, 2009
FOCUS ZONE REPORT – A handheld device that is able to predict whether patients will respond adversely to medication is a step closer to the market following work from a new partnership between Imperial College London and its spinout company DNA Electronics, who have developed a prototype healthcare device that assesses whether patients are genetically predisposed to suffering adverse reactions to prescription drugs.
 
deCODE genetics reveals SNPs that are link to increased risk of thyroid cancer
Development services : 09 February, 2009
Scientists at deCODE genetics have revealed the discovery of two single letter variations in the sequence of the human genome (SNPs) that confer substantial increased risk of thyroid cancer.
 
Philips enters into critical care joint development agreement with Immunetrics
Development services : 03 February, 2009
Philips and Immunetrics have entered into a joint development agreement to explore future-generation approaches to the problem of infectious disease in critical care.
 
Philips leads European project to develop image-guided localised drug delivery
Development services : 29 January, 2009
Philips is to lead a major new European project to develop drug delivery technologies that aims to impact the treatment of cancer and cardiovascular disease.
 
Philips and VTT open innovation centre in Finland for health technologies
Development services : 22 January, 2009
Philips and VTT have opened an InnoHub in the city of Espoo, close to Helsinki in Finland to generate innovative ideas relating to health, life-style and well-being with the aim to translate them into profitable businesses.
 
First | Prev  | 1 | 2  | Next  | Last
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo